LBGAX
Price
$39.39
Change
+$0.66 (+1.70%)
Updated
Apr 2 closing price
Net Assets
249.54M
VMGMX
Price
$107.34
Change
+$1.36 (+1.28%)
Updated
Apr 2 closing price
Net Assets
28.72B
Ad is loading...

LBGAX vs VMGMX

Header iconLBGAX vs VMGMX Comparison
Open Charts LBGAX vs VMGMXBanner chart's image
ClearBridge Mid Cap Growth A
Price$39.39
Change+$0.66 (+1.70%)
VolumeN/A
Net Assets249.54M
Vanguard Mid-Cap Growth Index Admiral
Price$107.34
Change+$1.36 (+1.28%)
VolumeN/A
Net Assets28.72B
LBGAX vs VMGMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LBGAX vs. VMGMX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBGAX is a StrongBuy and VMGMX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 28.7B vs. LBGAX (250M). VMGMX pays higher dividends than LBGAX: VMGMX (0.71) vs LBGAX (0.00). LBGAX was incepted earlier than VMGMX: LBGAX (15 years) vs VMGMX (14 years). LBGAX (1.35) is less costly to investors than VMGMX (0.07). LBGAX is a more actively managed with annual turnover of: 23.00 vs. VMGMX (14.00). LBGAX has a lower initial minimum investment than VMGMX: LBGAX (1000) vs VMGMX (3000). VMGMX annual gain was more profitable for investors over the last year : 6.28 vs. LBGAX (2.08). VMGMX return over 5 years is better than : 104.77 vs. LBGAX (77.91).
LBGAXVMGMXLBGAX / VMGMX
Total Expense Ratio1.210.071,729%
Annual Report Gross Expense Ratio1.350.071,929%
Fund Existence15 years14 years-
Gain YTD-8.763-2.984294%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets250M28.7B1%
Annual Yield % from dividends0.000.71-
Returns for 1 year2.086.2833%
Returns for 3 years6.5510.1365%
Returns for 5 years77.91104.7774%
Returns for 10 years62.66131.8948%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVVD0.580.04
+7.24%
Invivyd
SUPN32.821.14
+3.60%
Supernus Pharmaceuticals
SOFI12.310.40
+3.36%
SoFi Technologies
RLAY2.490.02
+0.81%
Relay Therapeutics
NVO68.240.21
+0.31%
Novo-Nordisk A/S